February 11, 2002  Vol. XIX, No. 7

Unfinished Business Named For New Congressional Year

When FDA Says No, External Review Panel Says Yes

Is Specialty Recognition Next for Pain Management?


Platelet Inhibitor May Be Reborn As Antiviral Agent for Herpes

New Aneuploid Screen Spots Down Syndrome in First Trimester


Diabetics Hope to Benefit From New Sugar-Coated Guidelines

IG Urges Medicare to Stop Paying For Multiple Shock Treatments




Speaking Their Language
Federal mandates and rising Hispanic populations have doctors reaching for the right words

 
Should psychedelic drugs be researched for therapeutic purposes?


Delayed Access

back to top

Reliant

© 2002 Physician’s Weekly, LLC